SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001535264-24-000031
Filing Date
2024-02-14
Accepted
2024-02-14 15:47:19
Documents
1
Group Members
ADAM STETTNERAWM INVESTMENT CO INC.DAVID GREENHOUSEMG ADVISERS, L.L.C.MGP ADVISERS LIMITED PARTNERSHIPSPECIAL SITUATIONS CAYMAN FUND, L.P.SPECIAL SITUATIONS FUND III QP, L.P.SPECIAL SITUATIONS PRIVATE EQUITY FUND, L.P.SSCAYMAN, L.L.C.

Document Format Files

Seq Description Document Type Size
1 OCX 13G/A OncoCyte13g123123t.txt SC 13G/A 7867
  Complete submission text file 0001535264-24-000031.txt   10064
Mailing Address 527 MADISON AVENUE SUITE 2600 NEW YORK NY 10022
Business Address 527 MADISON AVENUE SUITE 2600 NEW YORK NY 10022 212-319-6670
AWM Investment Company, Inc. (Filed by) CIK: 0001535264 (see all company filings)

IRS No.: 113086452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Subject) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89221 | Film No.: 24637104
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)